FDA Inspection 1290834 — Ansgar J. Weyergraf, M.D., Clinical Investigator
The FDA completed an inspection of Ansgar J. Weyergraf, M.D., Clinical Investigator on Oct 24, 2025 in Bramsche. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 24, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bramsche (Germany)
Additional details
Clinical Investigator (CI)